Amref Health Africa - UK
room Lower Ground Floor 15-18 White Lion Street London N1 9PD
arrow_back See all Activities

GSK 20% Reinvestment Initiative (Phase II)

IATI Identifier:

Published on IATI
  • date_range Jun 01, 2015 - May 31, 2020
  • autorenew Implementation (Status)

This project is to increase the numbers of mid-level health workers and community health workers in target 20% reinvestment countries through the scale up of pre-service and in-service training and through empowerment of communities. This is to improve the health of people living in the world’s poorest countries by ensuring access to health workers at the community level in Angola, Burundi, Ethipoia, Lesotho, Madagascar, Malawi, Mozambique, Rwanda, South Sudan, Tanzania, Uganda and Zambia. GlaxoSmithKline (GSK) is committed to reinvest 20% of profits made in the Least Developed Countries (LDCs) back into projects that strengthen the healthcare infrastructure in those countries, partnering with three leading NGOs to deliver the reinvestments: Amref Health Africa in East and Southern Africa, CARE International UK in Asia Pacific and Save the Children in West Africa. The shared objective of the investments will be to improve health outcomes by supporting frontline health workers who operate in these countries.

more_horiz
Sectors:

  • NCDs control, general

  • Basic drinking water supply and basic sanitation

Participating Organisations

GlaxoSmithKline (GSK) Private Sector in Provider Country Funding
Amref Health Africa - UK International NGO Accountable

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

5,933,548 USD
  • 922,103 GBP (Valued at Oct 30, 2019)
    date_range Jun 01, 2015 - May 30, 2016
  • 922,103 GBP (Valued at Oct 30, 2019)
    date_range Jun 01, 2016 - May 30, 2017
  • 922,103 GBP (Valued at Oct 30, 2019)
    date_range Jun 01, 2017 - May 30, 2018
  • 922,103 GBP (Valued at Oct 30, 2019)
    date_range Jun 01, 2018 - May 30, 2019
  • 922,103 GBP (Valued at Oct 30, 2019)
    date_range Jun 01, 2019 - May 30, 2020
access_time Updated on Feb 07, 2020 16:05:27